A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/14 (2006.01) A61K 31/00 (2006.01) C07C 233/00 (2006.01) C07D 233/00 (2006.01)
Patent
CA 2513746
A pharmaceutical composition comprising a co-crystal of an API and a co- crystal forming compound; wherein the API has at least one functional group selected from ether, thioether, alcohol, thiol, aldehyde, ketone, thioketone, nitrate ester, phosphate ester, thiophosphate ester, ester, thioester, sulfate ester, carboxylic acid, phosphonic acid, phosphinic acid, sulfonic acid, amide, primary amine, secondary amine, ammonia, tertiary amine, sp2 amine, thiocyanate, cyanamide, oxime, nitrile diazo, organohalide, nitro, s- heterocyclic ring, thiophene, n-heterocyclic ring, pyrrole, oheterocyclic ring, furan, epoxide, peroxide, hydroxamic acid, imidazole, pyridine and the co-crystal forming compound has at least one functional group selected from amine, amide, pyridine, imidazole, indole, pyrrolidine, carbonyl, carboxyl, hydroxyl, phenol, sulfone, sulfonyl, mercapto and methyl thio, such that the API and co-crystal forming compound are capable of co-crystallizing from a solution phase under crystallization conditions.
L'invention concerne une composition pharmaceutique comprenant un co-cristal de API et un composé formant un co-cristal. L'API présente au moins un groupe fonctionnel sélectionné parmi: éther, thioéther, alcool, thiol, aldéhyde, cétone, thiocétone, ester de nitrate, ester de phosphate, ester de thiophosphate, ester, thioester, ester de sulfate, acide carboxylique, acide phosphonique, acide phosphinique, acide sulfonique, amide, amine primaire, amine secondaire, ammoniac, amine tertiaire, amine sp2, thiocyanate, cianamide, oxime, diazo nitrile, organohalogénure, nitro, anneau s-hétérocyclique, thiophène, anneau n-hétérocyclique, pyrrole, anneau o-hétérocyclique, furane, époxyde, peroxyde, acide hydroxamique, imidazole, pyridine et le composé formant cristal présentant au moins un groupe fonctionnel sélectionné parmi: amine, amide, pyridine, imidazole, indole, pyrrolidine, carbonyle, carboxyle, hydroxyle, phénol, sulfone, sulfonyl, mercapto et méthyl thio, notamment, l'API et le composé formant un co-cristal pouvant réaliser une co-cristallisation à partir d'une phase de solution dans des conditions de cristallisation.
Almarsson Oern
Bourghol Hickey Magali
Moulton Brian
Peterson Matthew
Rodriguez-Hornedo Nair
Mcneil-Ppc Inc.
Osler Hoskin & Harcourt Llp
The Regents Of The University Of Michigan
Transform Pharmaceuticals Inc.
University Of South Florida
LandOfFree
Pharmaceutical co-crystal compositions of drugs such as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical co-crystal compositions of drugs such as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical co-crystal compositions of drugs such as... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1600344